These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34524886)

  • 21. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
    Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys
    Delgado JF; Vidal M; Julià G; Navarro G; Serrano RM; van den Eynde E; Navarro M; Calvet J; Gratacós J; Espasa M; Peña P
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status.
    Camacho J; Albert E; Zulaica J; Álvarez-Rodríguez B; Rusu L; Olea B; Alcaraz MJ; Geller R; Giménez E; Navarro D
    J Med Virol; 2023 Jan; 95(1):e28397. PubMed ID: 36504019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies.
    Nakagama Y; Komase Y; Kaku N; Nitahara Y; Tshibangu-Kabamba E; Tominaga T; Tanaka H; Yokoya T; Hosokawa M; Kido Y
    Microbiol Spectr; 2022 Aug; 10(4):e0098622. PubMed ID: 35867423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection.
    El-Khoury JM; Schulz WL; Durant TJS
    J Appl Lab Med; 2021 Jul; 6(4):1005-1011. PubMed ID: 33822964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of a flow cytometry-based immunoassay for detection of antibodies binding to SARS-CoV-2 spike protein.
    Valdivia A; Tarín F; Alcaraz MJ; Piñero P; Torres I; Marco F; Albert E; Navarro D
    Sci Rep; 2022 Jan; 12(1):586. PubMed ID: 35022478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
    Kohmer N; Westhaus S; Rühl C; Ciesek S; Rabenau HF
    J Clin Virol; 2020 Aug; 129():104480. PubMed ID: 32505777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.
    Theel ES; Johnson PW; Kunze KL; Wu L; Gorsh AP; Granger D; Roforth MM; Jerde CR; Lasho M; Andersen KJ; Murphy BM; Harring J; Lake DF; Svarovsky SA; Senefeld JW; Carter RE; Joyner MJ; Baumann NA; Mills JR
    J Clin Microbiol; 2021 Aug; 59(9):e0123121. PubMed ID: 34166066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays.
    Mafi S; Rogez S; Darreye J; Alain S; Hantz S
    Diagn Microbiol Infect Dis; 2023 Apr; 105(4):115900. PubMed ID: 36716586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months.
    Robertson LJ; Moore JS; Blighe K; Ng KY; Quinn N; Jennings F; Warnock G; Sharpe P; Clarke M; Maguire K; Rainey S; Price RK; Burns WP; Kowalczyk AM; Awuah A; McNamee SE; Wallace GE; Hunter D; Sager S; Chao Shern C; Nesbit MA; McLaughlin JAD; Moore T
    BMJ Open; 2021 Jun; 11(6):e048142. PubMed ID: 34187827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
    J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.
    Mueller T
    Clin Chim Acta; 2021 Jul; 518():9-16. PubMed ID: 33741357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
    Riester E; Findeisen P; Hegel JK; Kabesch M; Ambrosch A; Rank CM; Pessl F; Laengin T; Niederhauser C
    J Virol Methods; 2021 Nov; 297():114271. PubMed ID: 34461153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
    Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
    Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories.
    Plaga A; Wei R; Olson E; Payto D; Harrington J; Nwe-Kissig PT; Strizzi M; Zilka S; Ko J; Colón-Franco JM
    J Appl Lab Med; 2021 Jul; 6(4):998-1004. PubMed ID: 33825844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.